Related Experiment Video
Updated: Sep 3, 2026

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
Published on: January 28, 2021
Lipoprotein (a), cholesterol and triglycerides in women with venous thromboembolism
M D McColl1, N Sattar, J Ellison
1Department of Haematology, Royal Infirmary, Glasgow, UK. mmccoll1@aol.com
Insights
Lipoprotein (a) is not significantly linked to venous thromboembolism (VTE) in young women. However, obesity may increase VTE risk through higher triglyceride levels, impacting clotting factors.
Area of Science:
- Cardiovascular Science
- Hematology
- Metabolic Disorders
Background:
- Venous thromboembolism (VTE) is a significant health concern, particularly in younger women.
- Obesity is a known risk factor for VTE, but the underlying mechanisms require further elucidation.
- Lipid profiles, including lipoprotein (a), are being investigated for their role in VTE pathogenesis.
Purpose of the Study:
- To investigate the association between plasma lipoprotein (a) levels and objectively confirmed venous thromboembolism (VTE) in women aged 50 years or younger.
- To examine differences in lipid profiles (total cholesterol, HDL-cholesterol, LDL-cholesterol, triglyceride) between VTE cases and controls.
- To assess the influence of body mass index (BMI) on these associations.
Main Methods:
- A case-control study involving 62 women with VTE and 98 age-matched female controls.
- Measurement of plasma concentrations of lipoprotein (a), total cholesterol, HDL-cholesterol, LDL-cholesterol, and triglyceride.
- Statistical analysis to compare lipid profiles and assess the impact of BMI.
Main Results:
- Cases had significantly higher mean BMI and plasma triglyceride levels compared to controls.
- Cases exhibited significantly lower total cholesterol and HDL-cholesterol levels.
- After adjusting for BMI, total cholesterol and LDL-cholesterol remained significantly lower in cases.
- No significant difference in mean plasma lipoprotein (a) levels was observed between VTE cases and controls.
Conclusions:
- Plasma lipoprotein (a) does not appear to be significantly associated with the development of VTE in young women.
- The increased VTE risk in obese individuals may be partly mediated by hypertriglyceridaemia.
- Hypertriglyceridaemia's potential effects on coagulation factors and inhibitors warrant further investigation in the context of VTE risk.
Abstract:
Plasma concentrations of lipoprotein (a), total cholesterol, high-density lipoprotein (HDL)-cholesterol, low-density lipoprotein (LDL)-cholesterol and triglyceride were measured in 62 women who had suffered an episode of objectively confirmed venous thromboembolism (VTE) at < or = 50 years of age, and in 98 age-matched female controls. The mean body mass index (BMI) of cases was significantly (P < 0.001) higher than that of controls. Plasma triglyceride was significantly higher, and total cholesterol/LDL- and HDL-cholesterol significantly lower, in cases compared with controls. After adjustment for BMI, the plasma total cholesterol and LDL-cholesterol remained significantly lower in cases. No significant differences in mean plasma lipoprotein (a) levels were identified between cases and controls. Lipoprotein (a) does not appear to be significantly associated with the development of VTE in young women. The increased risk of VTE in obese subjects may be mediated, at least in part, via hypertriglyceridaemia, which has previously been demonstrated to have effects on levels of coagulation factors, natural anticoagulants, and plasminogen activator inhibitor type 1.
Related Concept Videos
Cholesterol: Significance and Regulation
Considering cholesterol and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Venous Thrombosis I: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management

